EDGAR Filing Documents for 0001193125-19-262726

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-19-262726

Filing Date

2019-10-04

Accepted

2019-10-04 16:06:28

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d813273ds3.htm	S-3	414735
2	EX-1.2	d813273dex12.htm	EX-1.2	176832
3	EX-4.3	d813273dex43.htm	EX-4.3	35851
4	EX-4.4	d813273dex44.htm	EX-4.4	263869
5	EX-5.1	d813273dex51.htm	EX-5.1	33709
6	EX-23.1	d813273dex231.htm	EX-23.1	1803
7	GRAPHIC	g813273g1003090845321.jpg	GRAPHIC	6856
8	GRAPHIC	g813273g61j23.jpg	GRAPHIC	32072
	Complete submission text file	0001193125-19-262726.txt		981787

Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080

Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412

SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-234101 | Film No.: 191138694
SIC: 2836 Biological Products, (No Diagnostic Substances)